Assembly of targeting complexes driven by a single-chain antibody

Journal of Immunological Methods

Volumn 289, Issue 1-2, 2004, Pages 37-45

  Backer, Marina V ^a   Elliot, Jennifer ^a   Gaynutdinov, Timur I ^a   Backer, Joseph M ^a  

^a SIBTECH INC   (United States)

Author keywords

KDR Fc; PEI; polyethylenimine; scFv; scFv antibody; Shiga like toxin; single chain fragment; SLT; soluble VEGFR 2; Targeted drug delivery; vascular endothelial growth factor; vascular endothelial growth factor receptor 2; VEGF; VEGFR 2

Indexed keywords

CELL PROTEIN; DNA; LUCIFERASE; PANCREATIC RIBONUCLEASE; PLASMID DNA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VITRONECTIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; CELLS, CULTURED; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RECOMBINANT PROTEINS; RIBONUCLEASE, PANCREATIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

BOVINAE;

EID: 3142526202     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.03.011     Document Type: Article

References (14)

1. Backer M.V., Backer J.M. Functionally active VEGF fusion proteins. Prot. Expr. Purif. 23:2001;1
2. Backer M.V., Backer J.M. Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteins. Bioconj. Chem. 12:2001;1066
3. Backer M.V., Aloise R., Przekop K., Stoletov K., Backer J.M. Molecular vehicles for targeted drug delivery. Bioconj. Chem. 13:2002;462
4. Backer M.V., Gaynutdinov T.I., Gorshkova I.I., Crouch R.J., Hu T., Aloise R., Arab M., Przekop K., Backer J.M. Humanized docking system for assembly of targeting drug delivery complexes. J. Control. Release. 89:2003;499
5. Backer M.V., Gaynutdinov T.I., Patel V., Jening B., Myshkin E., Backer J. Adapter protein for site-specific conjugation of payloads for targeted drug delivery. Bioconjug. Chem. 2004;. (submitted for publication)
6. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Guidi A.J., Dvorak H.F., Senger D.R., Connolly J.L., Schnitt S.J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26:1995;86
7. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Manseau E.J., Dvorak H.F., Senger D.R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143:1993;1255
8. Dubel S. Reconstitution of human pancreatic RNase from two separate fragments fused to different single chain antibody fragments: on the way to binary immunotoxins. Tumor Target. 4:1999;37
9. Gaynutdinov T.I., Myshkin E., Backer J.M., Backer M.V. Chimeric ribonuclease as a source of human adapter protein for targeted drug delivery. Prot. Eng. 16:2003;771
10. Kaplan J., Sridharan L., Zaccardis J., Doughter-Vermazen M., Terman B. Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera. Growth Factors. 14:1997;243
11. Lu D., Kotanides H., Jimenez X., Zhou Q., Persaud K., Bohlen P., Witte L., Zhu Z. Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2. J. Immunol. Methods. 230:1999;159
12. Neilsen U.B., Marks J.D. Internalizing antibodies and targeted cancer therapy: direct selection from phage display libraries. PSTT. 3:2000;282
13. Plate K.H., Breier G., Millauer B., Ullrich A., Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53:1993;5822
14. Wu A.M., Yazaki P.J. Designer genes: recombinant antibody fragments for biological imaging. Q. J. Nucl. Med. 43:1999;268